Publications
187
Citations
14,457
Est. group size
~5
Recurring co-author estimate
Active years
46
Publishing since 1980
Typically publishes in teams of ~7 · 32% small-team papers (≤3 authors) · across 12 venues
- Should CAR-T cells be used as monotherapy?
Current Opinion in Rheumatology · 2025
- SGLT-2 inhibitors: new horizons for rheumatologists
Current Opinion in Rheumatology · 2024
- Glucocorticoid-induced osteoporosis in premenopausal women: management for the rheumatologist
Current Opinion in Rheumatology · 2023
- Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature
Annals of the Rheumatic Diseases · 2022
- Hypomethylation of miR-17-92 cluster in lupus T cells and no significant role for genetic factors in the lupus-associated DNA methylation signature
medRxiv · 2022
- 1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons
2022
- Editorial: Quinacrine: au Revoir or Adieu? This safe and effective drug should be reintroduced
Current Opinion in Rheumatology · 2021
- 1507 The relationship between DNA methylation patterns and disease activity in a longitudinal multi-ancestral cohort of lupus patients
Abstracts · 2021
- A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients
JCI Insight · 2020
- OP0167 SUCCESSFUL WITHDRAWAL OF MYCOPHENOLATE MOFETIL IN QUIESCENT SLE: RESULTS FROM A RANDOMIZED TRIAL
Annals of the Rheumatic Diseases · 2020
- O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease
Oral Presentations · 2020
- DNA methylation patterns and disease activity in a longitudinal cohort of lupus patients
medRxiv · 2020
- Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2019
- Treatment of primary and secondary immune thrombocytopenia
Current Opinion in Rheumatology · 2019
- Ovarian protection with gonadotropin-releasing hormone agonists during cyclophosphamide therapy in systemic lupus erythematosus
Best Practice & Research Clinical Obstetrics & Gynaecology · 2019
- Current Opinion in Rheumatology×12
- Annals of the Rheumatic Diseases×7
- Arthritis & Rheumatology×5
- Lupus×3
- Arthritis Care & Research×2
- Emily C. Somers
Medicine · University of Michigan
- Michelle Petri
Medicine · University of Michigan
- Wendy Marder
Medicine · University of Michigan
- Amy Hurst
Medicine · University of Michigan
- E. Grau Garcia
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile